Ureteroscopy
Ureteroscopy
What is ureteroscopy?
Ureteroscopy is a minimally invasive method to treat kidney stones as well as stones located in the ureter. It is performed in the operating room with general or spinal anesthesia and is typically an outpatient procedure (you go home the same day).
Why is ureteroscopy done?
Urologists use ureteroscopy to remove stones that are stuck in the ureter and are closer to the bladder than the kidney (in the lower third of the ureter). But newer technology is allowing ureteroscopy to be used even for small stones in or near the kidney.
Appointment Information
U-M Health Urology is accepting new patients for initial and second opinions. Our medical staff’s goal is to see and evaluate patients based on their symptoms and urologic needs in a timely manner. For more information, call 734–936–7030.
How is ureteroscopy done?
How do I care for myself after ureteroscopy?
Most people are able to go home the same day of the procedure. But you may need to stay in the hospital. If you do, the stay is usually no more than 24 to 48 hours.
For several hours after the procedure you may have a burning feeling when you urinate. This feeling should go away within a day. Drinking a lot of water can help. Your doctor also may advise you to take medicine that numbs the burning. This medicine is called phenazopyridine. It is available by prescription and over the counter. Brand names include Pyridium and Uristat.
You may have some blood in your urine for 2 or 3 days.
Your doctor may prescribe an antibiotic for a day or two. This will help prevent an infection.
Doctors
Sapan Nitin Ambani, MD
Clinical Associate Professor
Urology
Casey Andrew Dauw, MD
Clinical Associate Professor
Urology
Khurshid Ridwan Ghani, MBCHB
Clinical Professor
Urology
William Woodruff Roberts, MD
Professor
Urology
News & Stories
Many hospitals still don’t do enough to prevent UTIs from catheters
U-M Regents approve Michigan Medicine leadership changes
Long friendship inspires urology resident fund
Researchers create new path to target hard-to-drug prostate cancer protein
Urine-based test detects aggressive prostate cancer